Management of multiple myeloma during COVID-19 pandemic

At the end of 2019, a novel coronavirus was identified as the cause of pneumonia cases in Wuhan, a city in the Hubei Province of China. On January 30, 2020, the World Health Organization (WHO) declared the COVID-19 outbreak a public health emergency of international concern and, in March 2020, began...

Descripción completa

Detalles Bibliográficos
Autores principales: Jethava, YS, Fonseca, Rafael, Landgren, Ola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7293439/
https://www.ncbi.nlm.nih.gov/pubmed/32704473
http://dx.doi.org/10.1016/j.lrr.2020.100212
_version_ 1783546304627998720
author Jethava, YS
Fonseca, Rafael
Landgren, Ola
author_facet Jethava, YS
Fonseca, Rafael
Landgren, Ola
author_sort Jethava, YS
collection PubMed
description At the end of 2019, a novel coronavirus was identified as the cause of pneumonia cases in Wuhan, a city in the Hubei Province of China. On January 30, 2020, the World Health Organization (WHO) declared the COVID-19 outbreak a public health emergency of international concern and, in March 2020, began to characterize it as a pandemic. The virus that causes COVID-19 is designated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) In February 2020, the World Health Organization designated the disease COVID-19, which stands for coronavirus disease 2019.
format Online
Article
Text
id pubmed-7293439
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-72934392020-06-14 Management of multiple myeloma during COVID-19 pandemic Jethava, YS Fonseca, Rafael Landgren, Ola Leuk Res Rep Article At the end of 2019, a novel coronavirus was identified as the cause of pneumonia cases in Wuhan, a city in the Hubei Province of China. On January 30, 2020, the World Health Organization (WHO) declared the COVID-19 outbreak a public health emergency of international concern and, in March 2020, began to characterize it as a pandemic. The virus that causes COVID-19 is designated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) In February 2020, the World Health Organization designated the disease COVID-19, which stands for coronavirus disease 2019. Elsevier 2020-06-13 /pmc/articles/PMC7293439/ /pubmed/32704473 http://dx.doi.org/10.1016/j.lrr.2020.100212 Text en © 2020 Published by Elsevier Ltd. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Jethava, YS
Fonseca, Rafael
Landgren, Ola
Management of multiple myeloma during COVID-19 pandemic
title Management of multiple myeloma during COVID-19 pandemic
title_full Management of multiple myeloma during COVID-19 pandemic
title_fullStr Management of multiple myeloma during COVID-19 pandemic
title_full_unstemmed Management of multiple myeloma during COVID-19 pandemic
title_short Management of multiple myeloma during COVID-19 pandemic
title_sort management of multiple myeloma during covid-19 pandemic
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7293439/
https://www.ncbi.nlm.nih.gov/pubmed/32704473
http://dx.doi.org/10.1016/j.lrr.2020.100212
work_keys_str_mv AT jethavays managementofmultiplemyelomaduringcovid19pandemic
AT fonsecarafael managementofmultiplemyelomaduringcovid19pandemic
AT landgrenola managementofmultiplemyelomaduringcovid19pandemic

Ejemplares similares